Medicinal Cannabis in Spain: Seventh World Power in 2025
Share
Production and licenses
Spain has 25 entities authorized for the cultivation of medicinal cannabis, with a 150% increase in licenses compared to 2019. Companies like Linneo Health can produce up to 25 tons annually.
Regulatory advances
Authorization of specific medicines, such as Sativex and Epidyolex, for multiple sclerosis and epilepsy is maintained. Access to medicinal cannabis requires a prescription and authorization from the Spanish Medicines Agency.
Role in the global market
Spain leads European research and production, expanding its participation in clinical trials and pharmaceutical development.
